Más del 70 por ciento de portadores en México ignoran que tienen Hepatitis C
Se calcula que en México poco más de un millón de hombres y mujeres, entre 30 y 70 años de edad, padecen Hepatitis C, pero sólo una tercera parte recibe tratamiento oportuno y tiene posibilidad de curación.
Governo quer fazer testes de HIV, hepatite e sífilis em todos os índios do país
O governo lança neste mês um programa destinado a realizar testes rápidos de HIV, sífilis e hepatites B e C em todas as aldeias indígenas do Brasil.
Pill targeting hepatitis C launched in the UK
A new pill that directly targets hepatitis C for the first time has been launched in the UK.
In clinical trials, adding Victrelis to standard therapy increased the number of chronic patients freed from the virus up to threefold.
Immunization protects 80 mln Chinese from hepatitis B infection
China credited its national immunization program which protected about 80 million people from being infected with the Hepatitis B virus (HBV) in the 19 years after 1992, when the virus was first brought into the program.
Pakistani Region Tackling Hepatitis C With Free Treatment
The government of Pakistan's northwestern Khyber Pakhtunkhwa Province is offering free treatment for hepatitis C patients for families with lower incomes, RFE/RL's Radio Mashaal reports.
Scientists a step closer to Hepatitis C vaccine
European scientists say they have successfully tested in animals a vaccine for hepatitis C, a contagious and debilitating virus that can cause liver failure and cancer.
New hepatitis C drug exciting -- but expensive
A new drug has just been approved by Health Canada for hepatitis C that might put the word "cure" within reach of some patients -- something unheard of with current treatments. But the drug comes with a hefty price tag and it's unclear who will be paying for it.
Chronic Hepatitis C Genotype 1 Drug, Victrelis (Boceprevir) Launched In UK
Victrelis (boceprevir), the first licenced medication to directly target the hepatitis virus was launched today in the United Kingdom. Victrelis is said to help clear the virus in nearly three times as many patients who did not respond properly to prior treatment, and nearly twice as many treatment naïve patients, compared to just current therapy.
Battling Hepatitis in West Africa
West African health experts are calling for governments to take the prevalence of hepatitis B and C more seriously, and to act to reduce the cost of treatment as part of more effective control of the disease.
The hepatitis B virus is responsible for more than 80 percent of liver cancers in Africa, said the coordinator of Senegal's National Programme Against Hepatitis, Aminata Sall Diallo, during an international meeting held in the Senegalese capital, Dakar, from Jul. 27 to 29.
Specter of hepatitis B rears its head again
Pregnant mainland mothers and sexually active locals are driving a hepatitis B epidemic in the territory, according to the Hong Kong Family Planning Association.
This is despite an immunization program that has freed children in the SAR from the virus, which can lead to cirrhosis, liver cancer and death.
Hong Kong launched its childhood immunization program for hepatitis B in 1988.